Main Menu

Cancer Types

Symptom Management

Treatment Types

Topics

Bleomycin - Chemotherapy Drug

chemotherapy drugs

One of the older chemotherapy drugs currently in widespread use, bleomycin was first discovered in 1966 by Japanese scientists, and much of the early research done on bleomycin's anticancer activity was carried out in Japanese laboratories. The drug is produced by the bacterium Streptomyces verticillus.

Bleomycin profile

  • Class: Antitumor glycopeptide antibiotic
  • Mechanism of action: Bleomycin works chiefly by causing breaks in the DNA strands within the cell.
  • Treatment type: Chemotherapy
  • US approval: 1973
  • Synonyms: Blenoxane, Bleo
  • FDA Use-in-Pregnancy Rating: Category D

What Bleomycin is effective for and why

Bleomycin has been a major player in chemotherapy, both by itself and in combination regimens for almost four decades. It has applications in several cancers, including Hodgkins lymphoma, cervical cancer, testicular cancer, penile cancer, squamous cell carcinomas, some non-Hodgkins lymphomas, esophageal cancer, and melanoma, to name a few. It is also part of the combination regimens ABVD, Stanford V, MACOP-B, and BEACOPP.

Bleomycin side effects: Overview

While each patient will have his or her own experiences with the side effects of bleomycin, it is not uncommon for patients to endure fever, chills, rash, anorexia, shortness of breath, sudden chest pains, or mouth sores. Most of these side effects should subside when one is finished with receiving bleomycin. Patients are encouraged to report all side effects to their oncologist or oncology team.

Beyond these side effects, bleomycin's considerable toxicity to the lungs, such as reversible and irreversible fibrosis, is well-known and well-documented. Patients with prior renal impairment are also cautioned about receiving bleomycin.

Sources

  • Boyiadzis, Michael M. et al. Hematology-Oncology Therapy. 2007. New York: McGraw Hill, Medical Publishing Division.
  • Guide to Cancer Drugs, American Cancer Society
  • Cancer Drug Manual, BC Cancer Agency
  • Perry, Michael C, Editor. Companion Handbook to the Chemotherapy Sourcebook. 1999. Baltimore; Williams & Wilkins.
  • Drugs.com: Bleomycin

Significant studies relating to Bleomycin


 
disclaimer

The information provided on CancerTreatment.net is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of CancerTreatment.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.

You May Also Want To Read

 

Other People Are Also Reading

 

Cancer Support Groups

visit SupportGroups.com

Cancer Support Groups at SupportGroups.com provide a support network for those facing life's challenges. Click on the following links to get a helping hand in a confidential, caring environment.

Selected Support Groups

 
randomness